{"name":"Teva Women's Health","slug":"teva-women-s-health","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DR-103","genericName":"DR-103","slug":"dr-103","indication":"Treatment of moderate to severe vasomotor symptoms associated with menopause","status":"phase_3"}]}],"pipeline":[{"name":"DR-103","genericName":"DR-103","slug":"dr-103","phase":"phase_3","mechanism":"DR-103 is a medication used to treat a specific condition by targeting a particular biological pathway.","indications":["Treatment of moderate to severe vasomotor symptoms associated with menopause"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPNVJxUWhOeTMwWXVHTC1uM2Y4OHcyTGpqdDRXT2JISHViZnZXaGFjcWhZSzU0VDZUb2hJYm1ZeG10UDJscmE5YnlUMnFDc240R0ZwVi1HSU9UNThwa25fS0dHZC00b0MzdXhldEUtdjRfZkhPNmpnWjFaNy1hT1VVcF9R?oc=5","date":"2025-11-19","type":"pipeline","source":"Yahoo Finance","summary":"Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges - Yahoo Finance","headline":"Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Healt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNTmpKYWh6V29lRWQtUGZCbWVnRHU1UVQzaDQ5RVNzaGpfTGJBRnAxcGNUb2dxMGlTS1J3UVJRTW9ickloTl94azJiVld1WktjRWFmY2RkcmZpVnV1Q2dvN0UxVE1rd1c5ZzJIUE84OWE5ck1sWFFRN3Q4d0F4NFhwdFJqLVR4YzBBSFd0SHRPUFJ5WjQ?oc=5","date":"2025-02-27","type":"pipeline","source":"Yahoo Finance","summary":"Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now? - Yahoo Finance","headline":"Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNX2J4S3VfampfeEFHbUF2ZVJTRDExQlBfNmVPcm5pLW9CZjNIOUtSaTJTRElCT0Y0WUoyUV83VXowOEZHRm5wbDZVeFBkeXFtVV9MUTZmZElXUVlBd0xldFJiTllWcGdrZnhxeU13TEZaaGNBMldzdUl5T2k3alFtdkxtY3liVGh3UUVfRENHVUhsNUNkMFdiQnIydW1Oc0VtSmN0SkF3?oc=5","date":"2025-02-21","type":"deal","source":"Fierce Pharma","summary":"Cosette sets sights on women's healthcare stardom with $430M Mayne Pharma buy - Fierce Pharma","headline":"Cosette sets sights on women's healthcare stardom with $430M Mayne Pharma buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPMTVxRWRacXZheHBtTEx0Wnp2ekt6cHhkZ3Z2TmhDWlV0Mzd2clJESElyUE5nNXN1UmhrNGhDZVhWV3J3UmJfNFBpb1VnLVphNHkta010UkRDWFRiMkcwLWRBT2FYdlhORGtnUzJnYk11dWxOMkRIdHN1QlBiaHVjUW1hc2dQRjNBcVlHeTJNaXRza1RiOXJOUldzUnFXRzZjQ0c0VHNn?oc=5","date":"2021-03-16","type":"deal","source":"Fierce Pharma","summary":"AbbVie revives Allergan's abandoned women's health sale, eyeing $5B deal - Fierce Pharma","headline":"AbbVie revives Allergan's abandoned women's health sale, eyeing $5B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQMUt6S2pkVmZpdG14RUlxOGJ1X21ZQkpkS0tRQzdnOGlxS25XZnJIR21FcXNRcW5GVkNjUkpIVFFMX0pPVVNwWnVIUlkzcjNiUXRVUEh6bnRmdHBfQmJTYmZ0V0Q2WlZDU1VBWXVCcWlCTHhLU3pOTy1SMk1HS3dTSzFKTk9uS28?oc=5","date":"2020-08-11","type":"deal","source":"BioPharma Dive","summary":"Bayer, contrasting pharma peers, builds up women’s health business with $425M deal - BioPharma Dive","headline":"Bayer, contrasting pharma peers, builds up women’s health business with $425M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOc0lMNlJRYl9zVml2Z2RtOWJvSU1rZjdqamdlaUtkUTBIcllHeHlabXQ5QUI5TFN4cnhhNEhJWE0tTlBneFh1MGVqZWptUXB0NXY2alRUc3ZOWUMycnMyeHpKUFRPSExXbDlsVXNwT04zcjYydHcxd3kxVHpoY09MYWdvV2U5eFhhbG9ZNzlUbTM0c3RVOVRqaEpxTDExYnpsckxmdmhOLVJUYkE?oc=5","date":"2018-02-02","type":"deal","source":"Pharmaceutical Technology","summary":"Teva concludes $703m women’s health products deal with CVC Capital - Pharmaceutical Technology","headline":"Teva concludes $703m women’s health products deal with CVC Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQdmFFUG9BQUFISlBSVXMxd05RVXhQZnVyNTd4MnFmc19iRjVUMFNmZ2NMQmp5aEpIUHBhVEwxVmh6WjB3UmQ4alRWMjZhalFiMTVkUGh6Z193YzNWQ194SVpTbHcyZXNzWmt0SHQ1X2dPVmVXenpPZk5DR1FhQ1dGNTZUX3FFeXB1VUVWN1pyUjdZMDBWSTk1bzl2ZUQ?oc=5","date":"2018-02-01","type":"pipeline","source":"Drug Delivery Business","summary":"Teva closes $703m sale of global women’s health biz to CVC Capital - Drug Delivery Business","headline":"Teva closes $703m sale of global women’s health biz to CVC Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQVjg3M3dRQktDX25FYzc5YVhmaF9IRFFjbUtJbUxOeG82UDA1YVJHUnh6TU5xX2pOR3llMkhiS1pvWDFpRFVMQ2xWdHNZcDRGdjBra0w5M3gwb1hoRG5RVllMa011SXRtbDdxaHJMakJ1b05LUThVV2NzOWhxSlAwckJQZVlyY3RUMkVTRG5JVQ?oc=5","date":"2017-09-19","type":"pipeline","source":"BioPharma Dive","summary":"Teva offloads the rest of its women’s health business for $1.4B - BioPharma Dive","headline":"Teva offloads the rest of its women’s health business for $1.4B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBBRFdFLU1TOUVLTjNKNWhWb3lQX2JRMzlYajloUWtaaTZhMFpMSGtrR1k4ZG13Z2dLNjVYWXNOTHpmUE5lY0JQbjlyQUYwb19BdFY0d2J1VE1IRXlrbWhPaFFhNjA5Q3QzV2c4cXdHX1E1MUJQSzhv?oc=5","date":"2017-09-18","type":"regulatory","source":"CTech","summary":"Teva Sells Remaining Women's Health Assets - CTech","headline":"Teva Sells Remaining Women's Health Assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZFFIelQ0SHcxQkNDMlNfb2R6cEJ3bkc2dGN4TWZHWmFsbVZvaGZFbGNXVDFkV0ZsTHF6Ulh1V3ZpeGU2Qmg1X3drUVdvOXo0cjNEcnRUT25RUGRmLWNVcWdQcTRnZlgxWGltNU0tQ2tjRG5TOGVNVjZnVjA4NUtxOHBvczU5ZzdpWVdQV2ZncnZWTy1ubTlTQTA1eUI4djZRY3BQZnBjQUMyS0ZrWkYzMWdKT3dZaDEw?oc=5","date":"2017-09-18","type":"pipeline","source":"reuters.com","summary":"Teva Pharma to sell more women's health assets for $1.38 billion - reuters.com","headline":"Teva Pharma to sell more women's health assets for $1.38 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQeFhoR3JLbXpReUsxQU1nVFNOT0hzZkwzZEYxT2dTUHIyYXR1NEpJNWFsM0w2ZTRkWlE5Tkd6Y1B5N0VVSXAtcUdxajBfSUVkYVJVVFhnclFYeUl2M2FDbnlpQ1A5TWlxQUdlZnhVYnl2andmMFU5RWt4d21Xc01vMUJOaUZMNFR5VU1WUVZSOVc0QQ?oc=5","date":"2017-09-18","type":"deal","source":"Drug Delivery Business","summary":"Teva sells off the rest of its women’s health assets in $2.5B deal - Drug Delivery Business","headline":"Teva sells off the rest of its women’s health assets in $2.5B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5nbC1LWEl0OXVCbUJiYlV1UmhPVlYwMzl2T1JJaEcyNDYxampXVWNSLWxjYnJ5aW5GSHBLbTlQZkdvMTY3OFVqYzY2UDg3bUdoTDlLV3AzaVZyWG82SFlTdDl2SWtrLTZpY25aRlNZcmdzOGpOU0hF?oc=5","date":"2017-09-14","type":"regulatory","source":"CTech","summary":"Teva Negotiating Sale of Remaining Women's Health Assets, Report Says - CTech","headline":"Teva Negotiating Sale of Remaining Women's Health Assets, Report Says","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}